Precision Biosciences (DTIL) Return on Sales (2018 - 2025)
Precision Biosciences (DTIL) has disclosed Return on Sales for 8 consecutive years, with 1538.62% as the latest value for Q3 2025.
- On a quarterly basis, Return on Sales fell 150430.0% to 1538.62% in Q3 2025 year-over-year; TTM through Sep 2025 was 123.22%, a 12322.0% decrease, with the full-year FY2023 number at 0.39%, up 116.0% from a year prior.
- Return on Sales was 1538.62% for Q3 2025 at Precision Biosciences, down from 1173.28% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 1.79% in Q4 2022 to a low of 1538.62% in Q3 2025.
- A 5-year average of 186.07% and a median of 1.14% in 2021 define the central range for Return on Sales.
- Peak YoY movement for Return on Sales: skyrocketed 3065bps in 2021, then tumbled -150430bps in 2025.
- Precision Biosciences' Return on Sales stood at 4.85% in 2021, then surged by 137bps to 1.79% in 2022, then tumbled by -123bps to 0.41% in 2023, then tumbled by -9074bps to 37.22% in 2024, then tumbled by -4034bps to 1538.62% in 2025.
- Per Business Quant, the three most recent readings for DTIL's Return on Sales are 1538.62% (Q3 2025), 1173.28% (Q2 2025), and 729.07% (Q1 2025).